We are live on
!
Find out more
Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$116B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
+11.31%
1 Year Est. Return
+26.37%
3 Year Est. Return
+67.38%
5 Year Est. Return
+85.79%
10 Year Est. Return
+313.78%
AUM
$112B
AUM Growth
+$6.13B
(+5.8%)
Cap. Flow
-$3B
Cap. Flow
% of AUM
-2.68%
Top 10 Holdings %
Top 10 Hldgs %
21.04%
Holding
3,037
New
148
Increased
1,035
Reduced
1,659
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$493M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$353M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$268M |
| 4 |
Elevance Health
ELV
|
+$196M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$330M |
| 3 |
Morgan Stanley
MS
|
+$284M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$277M |
| 5 |
Microsoft
MSFT
|
+$276M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.62% |
| 2 | Financials | 15.58% |
| 3 | Healthcare | 11.91% |
| 4 | Consumer Discretionary | 9.88% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Encore Capital Group
ECPG
$2.15B
| $432K | ﹤0.01% |
11,167
-65
| -0.6% | -$2.36K |
|
2202
Rocket Pharmaceuticals
RCKT
$367M
| $430K | ﹤0.01% |
175,703
+21,016
| +14% | +$106K |
|
2203
Select Water Solutions
WTTR
$2.63B
| $430K | ﹤0.01% |
49,812
+2,046
| +4% | +$17.7K |
|
2204
Amphastar Pharmaceuticals
AMPH
$858M
| $429K | ﹤0.01% |
18,688
-1,138
| -6% | -$28.2K |
|
2205
Compañía de Minas Buenaventura
BVN
$8.55B
| $429K | ﹤0.01% |
26,126
+3,000
| +13% | +$45.5K |
|
2206
Cimpress
CMPR
$2.37B
| $427K | ﹤0.01% |
9,078
-637
| -7% | -$27.8K |
|
2207
V2X
VVX
$2.55B
| $427K | ﹤0.01% |
8,788
+367
| +4% | +$17.5K |
|
2208
Trump Media & Technology Group
DJT
$2.31B
| $425K | ﹤0.01% |
23,577
-1,207
| -5% | -$26.3K |
|
2209
Nurix Therapeutics
NRIX
$2.82B
| $424K | ﹤0.01% |
37,214
+5,647
| +18% | +$61K |
|
|
PGRE
2210
DELISTED
Paramount Group
PGRE
| $422K | ﹤0.01% |
69,114
+2,350
| +4% | +$12.2K |
|
|
XRN
2211
Chiron Real Estate Inc
XRN
$484M
| $420K | ﹤0.01% |
12,117
+1,308
| +12% | +$45.6K |
|
|
PRA
2212
DELISTED
ProAssurance
PRA
| $419K | ﹤0.01% |
18,361
+32
| +0.2% | +$739 |
|
2213
HEICO Corp Class A
HEI.A
$38.1B
| $419K | ﹤0.01% |
1,620
+103
| +7% | +$22.5K |
|
2214
STAAR Surgical
STAA
$1.26B
| $419K | ﹤0.01% |
24,941
+174
| +0.7% | +$3.07K |
|
|
KW
2215
DELISTED
Kennedy-Wilson Holdings
KW
| $418K | ﹤0.01% |
61,434
+3,137
| +5% | +$20.9K |
|
2216
Integra LifeSciences
IART
$1.42B
| $416K | ﹤0.01% |
33,937
-331
| -1% | -$4.81K |
|
2217
Ducommun
DCO
$3.01B
| $414K | ﹤0.01% |
5,014
+155
| +3% | +$10.3K |
|
2218
Syndax Pharmaceuticals
SNDX
$1.7B
| $413K | ﹤0.01% |
44,149
+2,479
| +6% | +$27.3K |
|
2219
American Express Global Business Travel
GBTG
$4.94B
| $411K | ﹤0.01% |
65,254
-17,305
| -21% | -$111K |
|
2220
IMAX
IMAX
$2.92B
| $411K | ﹤0.01% |
14,692
+253
| +2% | +$6.57K |
|
|
SAFE
2221
Safehold
SAFE
$1.1B
| $409K | ﹤0.01% |
26,283
+1,553
| +6% | +$24.1K |
|
2222
Bank First Corp
BFC
$1.76B
| $409K | ﹤0.01% |
3,475
+35
| +1% | +$3.89K |
|
2223
Lionsgate Studios
LION
$3.49B
| $408K | ﹤0.01% |
+70,223
| New | +$470K |
|
|
MPT
2224
Medical Properties Trust
MPT
$2.51B
| $407K | ﹤0.01% |
94,528
-15,490
| -14% | -$76.6K |
|
2225
Lifestance Health
LFST
$4.67B
| $406K | ﹤0.01% |
78,593
-7,142
| -8% | -$42.8K |
|
Similar funds
Manulife (Manufacturers Life Insurance)'s Q2 2025 Portfolio in Review
As of Q2 2025, Manulife (Manufacturers Life Insurance) held 3,037 positions worth $112B, up 5.8% from $106B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Manulife (Manufacturers Life Insurance)'s Q2 2025 filing shows 148 new, 1,035 increased, 1,659 reduced and 133 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 217,719 shares worth $62.2M. The largest sale was Apple, an estimated $370M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Manulife (Manufacturers Life Insurance)'s largest Q2 2025 buy was iShares Russell 2000 Growth ETF: 217,719 shares worth $62.2M.
- Manulife (Manufacturers Life Insurance) added most to Hologic in Q2 2025, an estimated $493M increase.
- Manulife (Manufacturers Life Insurance)'s biggest Q2 2025 reduction was Apple, cutting an estimated $370M.
- Manulife (Manufacturers Life Insurance) fully exited iShares MSCI India ETF in Q2 2025, selling an estimated $128M.
- Manulife (Manufacturers Life Insurance)'s ten largest holdings make up 21% of its $112B portfolio in Q2 2025.
- Manulife (Manufacturers Life Insurance) opened 148 new positions and closed 133 in Q2 2025.
- Manulife (Manufacturers Life Insurance)'s portfolio value rose 5.8% quarter-over-quarter to $112B.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.